Discovering Gene therapy for APOE4-Associated Alzheimer’s Disease

Time: 11:00 am
day: Track B - Day 2


  • Reviewing the role of APOE in the pathogenesis of Alzheimer’s Disease
  • Understanding the approach of AAV-based gene therapy to treat Alzheimer’s Disease patients who are APOE homozygous
  • Describing the Phase 1 study design of LX1001